158 related articles for article (PubMed ID: 27320494)
1. Campylobacter bacteraemia: 16 years of experience in a single centre.
Hussein K; Raz-Pasteur A; Shachor-Meyouhas Y; Geffen Y; Oren I; Paul M; Kassis I
Infect Dis (Lond); 2016; 48(11-12):796-9. PubMed ID: 27320494
[TBL] [Abstract][Full Text] [Related]
2. Demographic and clinical characteristics of Campylobacter bacteremia in children with and without predisposing factors.
Ben-Shimol S; Carmi A; Greenberg D
Pediatr Infect Dis J; 2013 Nov; 32(11):e414-8. PubMed ID: 23694835
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008.
Liao CH; Chuang CY; Huang YT; Lee PI; Hsueh PR
J Infect; 2012 Nov; 65(5):392-9. PubMed ID: 22771419
[TBL] [Abstract][Full Text] [Related]
4. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors.
Nielsen H; Hansen KK; Gradel KO; Kristensen B; Ejlertsen T; Østergaard C; Schønheyder HC
Clin Microbiol Infect; 2010 Jan; 16(1):57-61. PubMed ID: 19673969
[TBL] [Abstract][Full Text] [Related]
5. [Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia].
González-Abad MJ; Alonso-Sanz M
Rev Esp Quimioter; 2013 Jun; 26(2):92-6. PubMed ID: 23817644
[TBL] [Abstract][Full Text] [Related]
6. Trends, clinical characteristics, antimicrobial susceptibility patterns, and outcomes of Campylobacter bacteraemia: a multicentre retrospective study.
Baek YJ; Song JE; Kim EJ; Choi H; Sohn Y; Jeon YD; Lee EH; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG; Kim JH
Infection; 2024 Jun; 52(3):857-864. PubMed ID: 37910310
[TBL] [Abstract][Full Text] [Related]
7. Campylobacter bacteremia in London: A 44-year single-center study.
O'Hara GA; Fitchett JRA; Klein JL
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):67-71. PubMed ID: 28629878
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.
Pigrau C; Bartolome R; Almirante B; Planes AM; Gavalda J; Pahissa A
Clin Infect Dis; 1997 Dec; 25(6):1414-20. PubMed ID: 9431389
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years.
Fernández-Cruz A; Muñoz P; Mohedano R; Valerio M; Marín M; Alcalá L; Rodriguez-Créixems M; Cercenado E; Bouza E
Medicine (Baltimore); 2010 Sep; 89(5):319-330. PubMed ID: 20827109
[TBL] [Abstract][Full Text] [Related]
10. Campylobacter bacteraemia in England and Wales, 1981-91.
Skirrow MB; Jones DM; Sutcliffe E; Benjamin J
Epidemiol Infect; 1993 Jun; 110(3):567-73. PubMed ID: 8519321
[TBL] [Abstract][Full Text] [Related]
11. Bacteremia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics.
Lu PL; Hsueh PR; Hung CC; Chang SC; Luh KT; Lee CY
J Formos Med Assoc; 2000 Aug; 99(8):612-7. PubMed ID: 10969503
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008.
Valenza G; Frosch M; Abele-Horn M
Scand J Infect Dis; 2010; 42(1):57-60. PubMed ID: 20055727
[TBL] [Abstract][Full Text] [Related]
13. Campylobacter spp. bacteremia in AIDS patients.
Pigrau C; Almirante B; Pahissa A; Bartolomé R
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):93-5. PubMed ID: 8624767
[No Abstract] [Full Text] [Related]
14. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
Evans MR; Northey G; Sarvotham TS; Rigby CJ; Hopkins AL; Thomas DR
Clin Infect Dis; 2009 Jun; 48(11):1500-6. PubMed ID: 19400688
[TBL] [Abstract][Full Text] [Related]
15. A laboratory-based survey of Campylobacter infections in Prahova County.
Sorokin M; Usein CR; Irimia M; Damian M
Roum Arch Microbiol Immunol; 2007; 66(3-4):85-9. PubMed ID: 18928068
[TBL] [Abstract][Full Text] [Related]
16. [A study of 30 patients with bacteremia due to Campylobacter spp].
Font C; Cruceta A; Moreno A; Miró O; Coll-Vinent B; Almela M; Mensa J
Med Clin (Barc); 1997 Mar; 108(9):336-40. PubMed ID: 9139156
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of bacteremia due to Campylobacter jejuni.
Mori T; Hasegawa N; Sugita K; Shinjoh M; Nakamoto N; Shimizu T; Hori S; Iketani O; Fujiwara H; Takano Y; Iwata S
Intern Med; 2014; 53(17):1941-4. PubMed ID: 25175126
[TBL] [Abstract][Full Text] [Related]
18. [Invasive Campylobacter jejuni/coli Infections: 9 Case Reports at a Single Center between 2000 and 2015, and a Review of Literature Describing Japanese Patients].
Tasaka K; Matsubara K; Nigami H; Iwata A; Isome K; Yamamoto G
Kansenshogaku Zasshi; 2016 May; 90(3):297-304. PubMed ID: 27529964
[TBL] [Abstract][Full Text] [Related]
19. Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study.
Gradel KO; Jensen US; Schønheyder HC; Østergaard C; Knudsen JD; Wehberg S; Søgaard M;
BMC Infect Dis; 2017 Feb; 17(1):122. PubMed ID: 28166732
[TBL] [Abstract][Full Text] [Related]
20. Increase of resistance to fluoroquinolone and retained susceptibility to macrolides of Campylobacter isolates in Croatia.
Šupraha P; Balen Topić M
Infect Dis (Lond); 2017 Oct; 49(10):781-784. PubMed ID: 28502195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
